SCHEMBL4551736

SCHEMBL4551736

O=C(O)c1ccc(-c2cnno2)cc1-c1cnno1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
USP2 O75604 1/20 0.37
TSHR P16473 1/20 0.37
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
LDHA P00338 1/20 0.35
LDHB P07195 1/20 0.35
HAO1 Q9UJM8 1/20 0.35
AKT1 P31749 1/20 0.34
PTPN1 P18031 2/20 0.34
RARA P10276 4/20 0.34
RARB P10826 4/20 0.34
RARG P13631 4/20 0.34
AURKA O14965 1/20 0.33
AURKB Q96GD4 1/20 0.33
HNF4A P41235 1/20 0.33
ACMSD Q8TDX5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4551737 0.79 KDM4E (0.54) ALDH1A1KDM4EUSP2TSHRNPC1
SCHEMBL3674766 0.78 NPC1 (0.46) ALDH1A1NPC1GAARAB9AKMT2A
SCHEMBL21598296 0.77 SNCA (0.38) ALDH1A1NPC1GAARAB9AKMT2A
SCHEMBL9135892 0.75 KDM4E (0.45) ALDH1A1KDM4ETSHRNPC1RAB9A
Hydrochloric Acid SCHEMBL1423177 0.72 LRRK2 (0.31) ALDH1A1TSHRKMT2A
SCHEMBL9134585 0.66 ALDH1A1 (0.43) ALDH1A1USP2NPC1RAB9AKMT2A
SCHEMBL797912 0.66 KDM4E (0.46) ALDH1A1KDM4ETSHRNPC1GAA
SCHEMBL9135821 0.65 HSD17B1 (0.50) ALDH1A1TSHRNPC1RAB9AKMT2A
SCHEMBL3673661 0.65 BCAT2 (0.49) ALDH1A1KDM4EUSP2TSHRNPC1
SCHEMBL6422582 0.64 CYP1A2 (0.44) ALDH1A1KDM4EUSP2TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019243971-A1 NOVEL COMPOUNDS AND THEIR METHODS OF USE THEREOF FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2019-12-26 WO claimed
EP-2970313-A1 SUBSTITUTED 7-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS Janssen Pharmaceutica N.V. (BE) 2016-01-20 EP disclosed
WO-2014159591-A1 SUBSTITUTED 7-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-02 WO disclosed
EP-2079466-A2 SUBSTITUTED INDOLE COMPOUNDS SmithKline Beecham Corporation (US) 2009-07-22 EP disclosed
WO-2008042571-A2 SUBSTITUTED INDOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-04-10 WO disclosed